Australia markets closed

AIM ImmunoTech Inc. (AIM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.4300+0.0045 (+1.06%)
At close: 03:59PM EDT
0.4400 +0.01 (+2.33%)
After hours: 06:53PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
135
141
135
163
Cost of revenue
176
0
850
806
Gross profit
-41
141
-715
-643
Operating expenses
Research development
7,806
6,990
7,672
5,720
Selling general and administrative
12,186
13,074
8,672
8,654
Total operating expenses
19,992
20,064
16,344
14,374
Operating income or loss
-20,033
-19,923
-17,059
-15,017
Interest expense
0
0
67
672
Total other income/expenses net
-1,065
-151
-2,001
1,289
Income before tax
-20,902
-19,445
-19,127
-14,400
Income from continuing operations
-20,902
-19,445
-19,127
-14,400
Net income
-20,902
-19,445
-19,127
-14,400
Net income available to common shareholders
-20,902
-19,445
-19,127
-14,400
Basic EPS
-0.43
-0.40
-0.40
-0.45
Diluted EPS
-0.43
-0.40
-0.40
-0.45
Basic average shares
48,383
48,047
47,340
31,843
Diluted average shares
48,383
48,047
47,340
31,843